165 related articles for article (PubMed ID: 34631264)
81. Body Mass Index and Melanoma Prognosis.
Cassano N; Caccavale S; Vena GA; Argenziano G
Dermatol Pract Concept; 2021 Sep; 11(4):e2021106. PubMed ID: 34631264
[TBL] [Abstract][Full Text] [Related]
82. Anthropometric factors and Breslow thickness: prospective data on 2570 cases of cutaneous melanoma in the population-based Janus Cohort.
Stenehjem JS; Veierød MB; Nilsen LT; Ghiasvand R; Johnsen B; Grimsrud TK; Babigumira R; Støer NC; Rees JR; Robsahm TE
Br J Dermatol; 2018 Sep; 179(3):632-641. PubMed ID: 29858512
[TBL] [Abstract][Full Text] [Related]
83. Body mass index (BMI) and outcome of metastatic melanoma patients receiving targeted therapy and immunotherapy: a multicenter international retrospective study.
Rutkowski P; Indini A; De Luca M; Merelli B; Mariuk-Jarema A; Teterycz P; Rogala P; Lugowska I; Cybulska-Stopa B; Labianca A; Di Guardo L; Del Vecchio M; Pigozzo J; Randon G; Corti F; Tondini CA; Rulli E; Mandala M
J Immunother Cancer; 2020 Nov; 8(2):. PubMed ID: 33203662
[TBL] [Abstract][Full Text] [Related]
84. Obesity and the Impact on Cutaneous Melanoma: Friend or Foe?
Smith LK; Arabi S; Lelliott EJ; McArthur GA; Sheppard KE
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32549336
[TBL] [Abstract][Full Text] [Related]
85. Adipocyte extracellular vesicles carry enzymes and fatty acids that stimulate mitochondrial metabolism and remodeling in tumor cells.
Clement E; Lazar I; Attané C; Carrié L; Dauvillier S; Ducoux-Petit M; Esteve D; Menneteau T; Moutahir M; Le Gonidec S; Dalle S; Valet P; Burlet-Schiltz O; Muller C; Nieto L
EMBO J; 2020 Feb; 39(3):e102525. PubMed ID: 31919869
[TBL] [Abstract][Full Text] [Related]
86. Decreased vitamin D serum levels at melanoma diagnosis are associated with tumor ulceration and high tumor mitotic rate.
Moreno-Arrones OM; Zegeer J; Gerbo M; Manrique-Silva E; Requena C; Traves V; Nagore E
Melanoma Res; 2019 Dec; 29(6):664-667. PubMed ID: 31469708
[TBL] [Abstract][Full Text] [Related]
87. The complex relationship between body mass index and response to immune checkpoint inhibition in metastatic melanoma patients.
Donnelly D; Bajaj S; Yu J; Hsu M; Balar A; Pavlick A; Weber J; Osman I; Zhong J
J Immunother Cancer; 2019 Aug; 7(1):222. PubMed ID: 31426863
[TBL] [Abstract][Full Text] [Related]
88. Environmental Exposures Such as Smoking and Low Vitamin D Are Predictive of Poor Outcome in Cutaneous Melanoma rather than Other Deprivation Measures.
Hardie CM; Elliott F; Chan M; Rogers Z; Bishop DT; Newton-Bishop JA
J Invest Dermatol; 2020 Feb; 140(2):327-337.e2. PubMed ID: 31425707
[TBL] [Abstract][Full Text] [Related]
89. Clinicopathologic Features and Prognostic Factors of Primary Cutaneous Melanoma: a Multicenter Study in Korea.
Kim JE; Chung BY; Sim CY; Park AY; Lee JS; Whang KU; Park YL; Kim HO; Park CW; Lee SY
J Korean Med Sci; 2019 Apr; 34(16):e126. PubMed ID: 31020815
[TBL] [Abstract][Full Text] [Related]
90. Obesity and cancer risk: Emerging biological mechanisms and perspectives.
Avgerinos KI; Spyrou N; Mantzoros CS; Dalamaga M
Metabolism; 2019 Mar; 92():121-135. PubMed ID: 30445141
[TBL] [Abstract][Full Text] [Related]
91. Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.
Wang Z; Aguilar EG; Luna JI; Dunai C; Khuat LT; Le CT; Mirsoian A; Minnar CM; Stoffel KM; Sturgill IR; Grossenbacher SK; Withers SS; Rebhun RB; Hartigan-O'Connor DJ; Méndez-Lagares G; Tarantal AF; Isseroff RR; Griffith TS; Schalper KA; Merleev A; Saha A; Maverakis E; Kelly K; Aljumaily R; Ibrahimi S; Mukherjee S; Machiorlatti M; Vesely SK; Longo DL; Blazar BR; Canter RJ; Murphy WJ; Monjazeb AM
Nat Med; 2019 Jan; 25(1):141-151. PubMed ID: 30420753
[TBL] [Abstract][Full Text] [Related]
92. Prognostic correlation between vitamin D serological levels, Body Mass Index and clinical-pathological features in melanoma patients.
Moliterni E; Paolino G; Veronese N; Bottoni U; Corsetti P; Cardone M; Didona D; Lopez T; Calvieri S
G Ital Dermatol Venereol; 2018 Oct; 153(5):732-733. PubMed ID: 30246955
[No Abstract] [Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
94.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
95.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
96.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
97.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
98.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
99.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
100.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
